What is happening in our network to improve cancer care and solve the mysteries of cancer? Here you will find examples of how different actors are pushing ahead in political and strategic issues, solving problems, financing research and developing new solutions.
Sweden
The Swedish Cancer Society in an independent non-profit organisation who works towards the vision of defeating cancer through financing the best cancer research in Sweden. In addition to financing research, the Society works to spread knowledge about cancer and prevention through its different channels.
The strategic mission of Genomic Medicine Sweden, GMS, is to foster collaboration between healthcare providers, academia and industry and realize precision medicine by effectively utilizing the rapidly advancing sequencing technologies to provide the highest standards of genomic testing in routine clinical care throughout Sweden.
Swedish Medtech is the trade association for medical technology. They work to make Sweden an attractive country for medical technology companies, which with value-based innovations increase patient safety and create sustainable care and care.
Läkemedelsindustriföreningen Lif is the trade association for the research-based pharmaceutical industry in Sweden. They work for high-quality care and access to new treatments by strengthening the Swedish Life Science sector in collaboration with healthcare actors, politicians, officials and patient representatives.
The foundation Swelife builds on the idea that we who live in Sweden should have access to preventive measures and knowledge for a life in health, and when we are sick we should have access to innovative, equal and personalized treatment.
Vinnova helps to build Sweden’s innovation capacity, contributing to sustainable growth. Their vision is that Sweden is an innovative force in a sustainable world.
This national strategy aims to strengthen the long-term competitiveness of Sweden as a life sciences nation. For the strategy to be successful, different sectors must contribute. Vision Zero Cancer brings actors together and sharpens the cooperation for several of the objectives in the strategy, such as Sweden being a pioneer in the implementation of precision medicine in health care services.
Swecare is a unique platform where academia, public and private sector join forces toward enhanced export and internationalization of Swedish healthcare and life science. Vision Zero Cancer is a member of Swecare.
Global and international efforts and networks
The European Commission has published an implementation roadmap and progress indicators for Europe’s Beating Cancer Plan to monitor developments on the ten flagship initiatives as well as its other actions. Vision Zero Cancer was involved in the consultation processes around the development of the plan almost a year ago.
London School of Economics report on personalised oncology in Europe mentions Vision Zero Cancer (page 40).
Under the Horizon Europe Framework Programme for Research and Innovation (2021-2027) five Missions aim to deliver solutions to major challenges for Europe. They include a Mission on Cancer. Many more people in Europe are living with cancer as the result of an ageing population, unhealthy lifestyles, and unfavourable social, environmental, and working conditions. This is generating a huge burden for citizens, cancer patients, survivors and their families, and for health systems and society at large. To deliver concrete solutions, the Board for the Mission on Cancer is proposing an ambitious goal: “By 2030, more than 3 million lives saved, living longer and better”.
Cancer Core Europe is a network whose members are driven by a strong will to reshape the cancer research model to ultimately increase the European Union’s competitiveness as a place to conduct cutting-edge research that’s translated to the clinic to deliver more personalized medicine.
The Global Lung Cancer Coalition (GLCC) is an international network of 38-member patient organizations from countries around the world.
AstraZeneca is not only one of the founders of the Vision Zero Cancer innovation milieu, but also one of four founders of the Global Lung Ambition Alliance initiative together with the Global Lung Cancer Coalition (GLCC), the International Association for the Study of Lung Cancer (IASLC) and Guardant Health.
All.Can is an international multi-stakeholder not-for-profit organisation working to improve the efficiency of cancer care by focusing on what matters to patients.
The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer.